A fenofibrate capsule. (Public Domain/ Dennis Sylvester Hurd, Flickr)
Jerusalem researchers say they have shown that an existing drug used to lower lipid levels significantly downgrades the intensity of COVID-19, after conducting a comparative study of 1,500 medical records from hospitalized patients.
Fenofibrate, a generic fat-lowering medication that is among the most prescribed drugs in the US, appeared to give patients an “astounding” advantage in fighting the disease
, Prof. Yaakov Nahmias of the Hebrew University of Jerusalem told The Times of Israel.
“This is a cheap and widely available drug with minimal side effects, and we were excited to find that all the main biomarkers indicate that it reduces the severity of COVID-19,” Nahmias said on Sunday